Specifications TableSubjectChemistrySpecific subject areaOrganic chemistry, removal kineticsType of dataTableHow data were acquiredSoftware SigmaPlotData formatAnalyzedParameters for data collectionThe first-order kinetic data were obtained through the exponential decay fitting in the Regression Wizard in SigmaPlot; the zero-order kinetic data were obtained through the linear fitting in Regression Wizard in SigmaPlot.Description of data collectionThe removal kinetic data were collected through the data analysis (Regression Wizard) in SigmaPlot.Data source locationUniversity of Waterloo,\
Waterloo, Ontario\
CanadaData accessibilityData are available in this articleRelated research articleYingYing Liu, David W. Blowes, Carol J. Ptacek, and Laura G. Groza\
Removal of pharmaceutical compounds, artificial sweeteners, and perfluoroalkyl substances from water using a passive treatment system containing zero-valent iron and biochar\
Science of the Total Environment\
[https://doi.org/10.1016/j.scitotenv.2019.06.450](10.1016/j.scitotenv.2019.06.450){#intref0010}**Value of the Data**•The data in this article provide important information on degradation kinetics such as removal rates and half-lives for 14 emerging contaminants treated by zero-valent iron (ZVI) and biochar (BC).•Researchers working in the field of remediation of emerging contaminants in water can benefit from the data in this article.•The data present in this article can provide useful information and guidelines for selecting the appropriate types of reactive media to remove specific emerging contaminants.•The removal kinetic data (removal rate and half-life) can be used to design reactors or permeable reactive barriers (PRBs) for future large-scale field applications.

1. Data {#sec1}
=======

The dataset showed the removal kinetic parameters, including removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~), for 14 target emerging contaminants in Column *ZVI*, Column *BC*, and Column *(ZVI* *+* *BC)*. The kinetic parameters for each contaminant are summarized in separate tables ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"}, [Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"}, [Table 7](#tbl7){ref-type="table"}, [Table 8](#tbl8){ref-type="table"}, [Table 9](#tbl9){ref-type="table"}, [Table 10](#tbl10){ref-type="table"}, [Table 11](#tbl11){ref-type="table"}, [Table 12](#tbl12){ref-type="table"}, [Table 13](#tbl13){ref-type="table"}, [Table 14](#tbl14){ref-type="table"}). The raw data (concentration vs. residence time) of each contaminant can be found in the related research article \[[@bib1]\].Table 1First-order removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of pharmaceutical ***carbamazepine*** in Column *ZVI*, Column *BC*, and Column *(ZVI + BC)*. *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the carbamazepine concentration.Table 1ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^\
(μg L^−1^ d^−1^)*k*~*obs*~,\
d^−1^*k*~*M*~,\
L g^−1^ d^−1^*k*~*SA*~,\
L m^−2^ d^−1^*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)111.1E+01 × *C*1.1E+012.6E-032.8E-040.060.999134.9 × *C*4.91.1E-031.2E-040.140.975254.4 × *C*4.41.0E-031.1E-040.160.9652531.2 × *C*1.22.9E-043.0E-050.560.931Column 3 (BC)115.4 × *C*5.41.2E-021.8E-040.190.998132.5 × *C*2.55.3E-038.2E-050.280.998251.9 × *C*1.94.2E-036.4E-050.360.9962530.7 × *C*0.71.5E-032.3E-051.00.970Column 4 (ZVI + BC)118.2 × *C*8.27.2E-032.1E-040.090.999134.5 × *C*4.53.9E-031.2E-040.160.966254.0 × *C*4.03.5E-031.0E-040.170.9702531.3 × *C*1.31.1E-033.3E-050.550.992Table 2First-order removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of pharmaceutical ***caffeine****in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the caffeine concentration.Table 2ColumnStagePVRemoval rate^ƚ^, μmol L^−1^ d^−1^\
(μg L^−1^ d^−1^)*k*~*obs*~,\
d^−1^*k*~*M*~,\
L g^−1^ d^−1^*k*~*SA*~,\
L m^−2^ d^−1^*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)111.6E+01 × *C*1.6E+013.7E-033.9E-040.040.999137.2 × *C*7.21.7E-031.8E-040.100.998255.1 × *C*5.11.2E-031.2E-040.140.9822531.5 × *C*1.53.5E-043.6E-050.470.961Column 3 (BC)114.8 × *C*4.81.0E-021.6E-040.140.999132.8 × *C*2.86.0E-039.4E-050.250.999252.2 × *C*2.24.8E-037.4E-050.310.9962531.0 × *C*1.02.1E-033.3E-050.700.973Column 4 (ZVI + BC)116.9 × *C*6.96.0E-031.8E-040.100.996135.5 × *C*5.54.8E-031.4E-040.130.989254.5 × *C*4.53.9E-031.2E-040.150.9732531.7 × *C*1.71.5E-034.5E-050.400.996Table 3First-order removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of pharmaceutical ***sulfamethoxazole****in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the sulfamethoxazole concentration. "--" represents not applicable.Table 3ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^\
(μg L^−1^ d^−1^)*k*~*obs*~,\
d^−1^*k*~*M*~,\
L g^−1^ d^−1^*k*~*SA*~,\
L m^−2^ d^−1^*t*~*0.5*~,\
d*R*^*2*^Column 1 (Control)1250.2 × *C*0.2----3.60.8772530.4 × *C*0.4----1.80.984Column 2 (ZVI)114.5E+02 × *C*4.5E+021.1E-011.1E-020.0021.000134.7E+02 × *C*4.7E+021.1E-011.1E-020.0011.000254.6E+02 × *C*4.6E+021.1E-011.1E-020.0011.0002531.5E+02 × *C*1.5E+023.5E-023.7E-030.0051.000Column 3 (BC)111.6 × *C*1.63.5E-035.4E-050.430.999131.2 × *C*1.22.5E-033.8E-050.600.999251.1 × *C*1.12.4E-033.8E-050.610.9932530.5 × *C*0.51.1E-031.7E-051.40.991Column 4 (ZVI + BC)114.5E+02 × *C*4.5E+024.0E-011.2E-020.0021.000134.7E+02 × *C*4.7E+024.1E-011.2E-020.0011.000254.6E+02 × *C*4.6E+024.1E-011.2E-020.0011.0002531.5E+02 × *C*1.5E+021.3E-013.9E-030.0051.000Table 4First-order removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of pharmaceutical ***3,4-methylenedioxyamphetamine (MDA)****in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the MDA concentration.Table 4ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^\
(μg L^−1^ d^−1^)*k*~*obs*~,\
d^−1^*k*~*M*~,\
L g^−1^ d^−1^*k*~*SA*~,\
L m^−2^ d^−1^*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)111.9E+02 × *C*1.9E+024.3E-024.6E-030.0041.000131.3E+01 × *C*1.3E+013.0E-033.1E-040.060.999257.8 × *C*7.81.8E-031.9E-040.090.9982532.4 × *C*2.45.5E-045.8E-050.290.996Column 3 (BC)111.1E+01 × *C*1.1E+012.4E-023.7E-040.060.999138.1 × *C*8.11.7E-022.7E-040.090.997255.1 × *C*5.11.1E-021.7E-040.140.9982533.2 × *C*3.26.8E-031.1E-040.220.997Column 4 (ZVI + BC)112.0E+01 × *C*2.0E+011.8E-025.3E-040.031.000131.2E+01 × *C*1.2E+011.0E-023.0E-040.060.999258.7 × *C*8.77.6E-032.3E-040.080.9992533.9 × *C*3.93.4E-031.0E-040.180.999Table 5First-order removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of pharmaceutical **3,4-methylenedioxymethamphetamine (MDMA)***in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the MDMA concentration.Table 5ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^\
(μg L^−1^ d^−1^)*k*~*obs*~,\
d^−1^*k*~*M*~,\
L g^−1^ d^−1^*k*~*SA*~,\
L m^−2^ d^−1^*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)113.0E+02 × *C*3.0E+026.9E-027.3E-030.0021.000133.5E+02 × *C*3.5E+028.2E-028.7E-030.0021.000251.4E+01 × *C*1.4E+013.2E-033.4E-040.051.0002534.0 × *C*4.09.3E-049.8E-050.171.000Column 3 (BC)111.1E+01 × *C*1.1E+012.3E-023.6E-040.070.999137.7 × *C*7.71.7E-022.6E-040.090.998255.2 × *C*5.21.1E-021.7E-040.130.9972533.1 × *C*3.16.7E-031.0E-040.220.997Column 4 (ZVI + BC)112.5E+01 × *C*2.5E+012.2E-026.6E-040.031.000131.6E+01 × *C*1.6E+011.4E-024.1E-040.041.000251.0E+01 × *C*1.0E+019.0E-032.7E-040.070.9992534.3 × *C*4.33.8E-031.1E-040.161.000Table 6First-order removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of pharmaceutical ***ibuprofen****in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the ibuprofen concentration.Table 6ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^\
(μg L^−1^ d^−1^)*k*~*obs*~,\
d^−1^*k*~*M*~,\
L g^−1^ d^−1^*k*~*SA*~,\
L m^−2^ d^−1^*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)112.6 × *C*2.66.0E-046.3E-050.270.943131.2 × *C*1.22.9E-043.0E-050.560.926250.9 × *C*0.92.2E-042.3E-050.740.9322530.2 × *C*0.24.7E-054.9E-063.50.864Column 3 (BC)111.9 × *C*1.94.2E-036.5E-050.360.992131.2 × *C*1.22.6E-034.0E-050.570.997251.1 × *C*1.12.4E-033.7E-050.630.9962530.4 × *C*0.48.9E-041.4E-051.70.992Column 4 (ZVI + BC)112.9 × *C*2.92.5E-037.6E-050.240.978131.7 × *C*1.71.5E-034.5E-050.410.958251.6 × *C*1.61.4E-034.1E-050.440.9522530.5 × *C*0.54.0E-041.2E-051.50.941Table 7First-order removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of pharmaceutical ***gemfibrozil****in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the gemfibrozil concentration.Table 7ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^\
(μg L^−1^ d^−1^)*k*~*obs*~,\
d^−1^*k*~*M*~,\
L g^−1^ d^−1^*k*~*SA*~,\
L m^−2^ d^−1^*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)119.3 × *C*9.32.2E-032.3E-040.070.999134.6 × *C*4.61.1E-031.1E-040.150.969253.5 × *C*3.58.2E-048.6E-050.200.9542531.0 × *C*1.02.4E-042.5E-050.670.927Column 3 (BC)114.5 × *C*4.59.7E-031.5E-040.150.997132.4 × *C*2.45.1E-038.0E-050.290.995251.8 × *C*1.83.8E-035.9E-050.390.9962530.6 × *C*0.61.4E-032.1E-051.10.981Column 4 (ZVI + BC)115.9 × *C*5.95.1E-031.5E-040.120.990133.5 × *C*3.53.1E-039.2E-050.200.967252.8 × *C*2.82.5E-037.4E-050.240.9352530.9 × *C*0.97.6E-042.3E-050.800.989Table 8First-order removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of pharmaceutical ***naproxen****in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the naproxen concentration.Table 8ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^\
(μg L^−1^ d^−1^)*k*~*obs*~,\
d^−1^*k*~*M*~,\
L g^−1^ d^−1^*k*~*SA*~,\
L m^−2^ d^−1^*t*~*0.5*~,\
dR^2^Column 2 (ZVI)115.7 × *C*5.71.3E-031.4E-040.120.988133.1 × *C*3.17.2E-047.6E-050.220.908252.8 × *C*2.86.4E-046.8E-050.250.9492530.6 × *C*0.61.4E-041.5E-051.20.941Column 3 (BC)113.7 × *C*3.78.0E-031.2E-040.190.999132.0 × *C*2.04.2E-036.6E-050.350.996251.7 × *C*1.73.6E-035.6E-050.410.9992530.6 × *C*0.61.4E-032.2E-051.10.985Column 4 (ZVI + BC)114.7 × *C*4.74.1E-031.2E-040.150.978133.0 × *C*3.02.6E-037.7E-050.230.959252.6 × *C*2.62.2E-036.7E-050.270.9772530.7 × *C*0.76.5E-041.9E-050.940.980Table 9Zero- or first-order removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of artificial sweetener ***acesulfame-K****in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. Removal rate constant *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the acesulfame-K concentration. "--" represents no removal of acesulfame-K was observed.Table 9ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^\
(μg L^−1^ d^−1^)*k*~*obs*~*k*~*M*~*k*~*SA*~*t*~*0.5*~,*R*^*2*^Column 2 (ZVI)112.3E-01 × *C*[a](#tbl9fna){ref-type="table-fn"}2.3E-01[a](#tbl9fna){ref-type="table-fn"}5.3E-05[a](#tbl9fna){ref-type="table-fn"}5.6E-06[a](#tbl9fna){ref-type="table-fn"}3.10.749131.0E-01 × *C*[a](#tbl9fna){ref-type="table-fn"}1.0E-01[a](#tbl9fna){ref-type="table-fn"}2.4E-05[a](#tbl9fna){ref-type="table-fn"}2.6E-06[a](#tbl9fna){ref-type="table-fn"}6.60.906259.8E-02 × *C*[a](#tbl9fna){ref-type="table-fn"}9.8E-02[a](#tbl9fna){ref-type="table-fn"}2.3E-05[a](#tbl9fna){ref-type="table-fn"}2.4E-06[a](#tbl9fna){ref-type="table-fn"}7.00.8742531.1E-01 × *C*[a](#tbl9fna){ref-type="table-fn"}1.1E-01[a](#tbl9fna){ref-type="table-fn"}2.7E-05[a](#tbl9fna){ref-type="table-fn"}2.8E-06[a](#tbl9fna){ref-type="table-fn"}6.10.870Column 3 (BC)111.6 E+01[b](#tbl9fnb){ref-type="table-fn"}1.6 E+01[b](#tbl9fnb){ref-type="table-fn"}3.4E-02[b](#tbl9fnb){ref-type="table-fn"}5.3E-04[b](#tbl9fnb){ref-type="table-fn"}3.20.86413------------25------------253------------Column 4 (ZVI + BC)115.9[b](#tbl9fnb){ref-type="table-fn"}5.8[b](#tbl9fnb){ref-type="table-fn"}5.1E-03[b](#tbl9fnb){ref-type="table-fn"}1.5E-04[b](#tbl9fnb){ref-type="table-fn"}8.30.976134.2[b](#tbl9fnb){ref-type="table-fn"}4.2[b](#tbl9fnb){ref-type="table-fn"}3.7E-03[b](#tbl9fnb){ref-type="table-fn"}1.1E-04[b](#tbl9fnb){ref-type="table-fn"}120.634254.9[b](#tbl9fnb){ref-type="table-fn"}4.9[b](#tbl9fnb){ref-type="table-fn"}4.3E-03[b](#tbl9fnb){ref-type="table-fn"}1.3E-04[b](#tbl9fnb){ref-type="table-fn"}100.8352533.2[b](#tbl9fnb){ref-type="table-fn"}3.2[b](#tbl9fnb){ref-type="table-fn"}2.8E-03[b](#tbl9fnb){ref-type="table-fn"}8.3E-05[b](#tbl9fnb){ref-type="table-fn"}170.866[^1][^2]Table 10Zero-order removal rate constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of artificial sweetener ***cyclamate****in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. Removal rate constant *k*~*obs*~ is calculated using least-squares regression during two experimental stages. "--" represents no removal of cyclamate was observed.Table 10ColumnStagePVRemoval rate,\
μmol L^−1^ d^−1^ (μg L^−1^ d^−1^)*k*~*obs*~,\
μmol L^−1^ d^−1^ (μg L^−1^ d^−1^)*k*~*M*~,\
μmol g^−1^ d^−1^ (μg g^−1^ d^−1^)*k*~*SA*~,\
μmol m^−2^ d^−1^ (μg m^−2^ d^−1^)*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)111.5E+011.5E+013.6E-033.8E-043.30.69713------------25------------253------------Column 3 (BC)118.48.41.8E-022.8E-045.80.83913------------25------------253------------Column 4 (ZVI + BC)112.02.01.8E-035.2E-05230.62413------------25------------253------------[^3]Table 11Zero- or first-order removal constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of artificial sweetener ***saccharin****in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. Removal rate constant *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the saccharin concentration. "--" represents no removal of saccharin was observed.Table 11ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^ (μg L^−1^ d^−1^)*k*~*obs*~*k*~*M*~*k*~*SA*~*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)113.5E+01[b](#tbl11fnb){ref-type="table-fn"}3.5E+01[b](#tbl11fnb){ref-type="table-fn"}8.1E-03[b](#tbl11fnb){ref-type="table-fn"}8.6E-04[b](#tbl11fnb){ref-type="table-fn"}1.50.898134.7[b](#tbl11fnb){ref-type="table-fn"}4.7[b](#tbl11fnb){ref-type="table-fn"}1.1E-03[b](#tbl11fnb){ref-type="table-fn"}1.2E-04[b](#tbl11fnb){ref-type="table-fn"}9.30.80425------------2531.7[b](#tbl11fnb){ref-type="table-fn"}1.7[b](#tbl11fnb){ref-type="table-fn"}3.9E-04[b](#tbl11fnb){ref-type="table-fn"}4.1E-05[b](#tbl11fnb){ref-type="table-fn"}320.583Column 3 (BC)111.0 × *C*[a](#tbl11fna){ref-type="table-fn"}1.0[a](#tbl11fna){ref-type="table-fn"}2.2E-03[a](#tbl11fna){ref-type="table-fn"}3.4E-05[a](#tbl11fna){ref-type="table-fn"}0.70.978130.5 × *C*[a](#tbl11fna){ref-type="table-fn"}0.5[a](#tbl11fna){ref-type="table-fn"}9.8E-04[a](#tbl11fna){ref-type="table-fn"}1.5E-05[a](#tbl11fna){ref-type="table-fn"}1.50.981252.4E+01[b](#tbl11fnb){ref-type="table-fn"}2.4E+01[b](#tbl11fnb){ref-type="table-fn"}5.2E-02[b](#tbl11fnb){ref-type="table-fn"}8.0E-04[b](#tbl11fnb){ref-type="table-fn"}2.20.9832532.6[b](#tbl11fnb){ref-type="table-fn"}2.6[b](#tbl11fnb){ref-type="table-fn"}5.6E-03[b](#tbl11fnb){ref-type="table-fn"}8.6E-05[b](#tbl11fnb){ref-type="table-fn"}210.828Column 4 (ZVI + BC)113.4E+01[b](#tbl11fnb){ref-type="table-fn"}3.4E+01[b](#tbl11fnb){ref-type="table-fn"}3.0E-02[b](#tbl11fnb){ref-type="table-fn"}8.9E-04[b](#tbl11fnb){ref-type="table-fn"}1.30.969131.4E+01[b](#tbl11fnb){ref-type="table-fn"}1.4E+01[b](#tbl11fnb){ref-type="table-fn"}1.2E-02[b](#tbl11fnb){ref-type="table-fn"}3.6E-04[b](#tbl11fnb){ref-type="table-fn"}3.10.960251.1E+01[b](#tbl11fnb){ref-type="table-fn"}1.1E+01[b](#tbl11fnb){ref-type="table-fn"}9.4E-03[b](#tbl11fnb){ref-type="table-fn"}2.8E-04[b](#tbl11fnb){ref-type="table-fn"}4.90.8452532.1[b](#tbl11fnb){ref-type="table-fn"}2.1[b](#tbl11fnb){ref-type="table-fn"}1.9E-03[b](#tbl11fnb){ref-type="table-fn"}5.6E-05[b](#tbl11fnb){ref-type="table-fn"}250.701[^4][^5]Table 12Zero- or first-order removal constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of artificial sweetener ***sucralose****in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. Removal rate constant *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the sucralose concentration.Table 12ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^ (μg L^−1^ d^−1^)*k*~*obs*~*k*~*M*~*k*~*SA*~*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)112.1 × *C*[a](#tbl12fna){ref-type="table-fn"}2.1[a](#tbl12fna){ref-type="table-fn"}4.8E-04[a](#tbl12fna){ref-type="table-fn"}5.1E-05[a](#tbl12fna){ref-type="table-fn"}0.30.922131.0 × *C*[a](#tbl12fna){ref-type="table-fn"}1.0[a](#tbl12fna){ref-type="table-fn"}2.4E-04[a](#tbl12fna){ref-type="table-fn"}2.5E-05[a](#tbl12fna){ref-type="table-fn"}0.70.927254.4E+01[b](#tbl12fnb){ref-type="table-fn"}4.4E+01[b](#tbl12fnb){ref-type="table-fn"}1.0E-02[b](#tbl12fnb){ref-type="table-fn"}1.1E-03[b](#tbl12fnb){ref-type="table-fn"}1.40.9632531.2E+01[b](#tbl12fnb){ref-type="table-fn"}1.2E+01[b](#tbl12fnb){ref-type="table-fn"}2.8E-03[b](#tbl12fnb){ref-type="table-fn"}2.9E-04[b](#tbl12fnb){ref-type="table-fn"}4.90.995Column 3 (BC)111.3 × *C*[a](#tbl12fna){ref-type="table-fn"}1.3[a](#tbl12fna){ref-type="table-fn"}2.7E-03[a](#tbl12fna){ref-type="table-fn"}4.2E-05[a](#tbl12fna){ref-type="table-fn"}0.50.999130.9 × *C*[a](#tbl12fna){ref-type="table-fn"}0.9[a](#tbl12fna){ref-type="table-fn"}1.9E-03[a](#tbl12fna){ref-type="table-fn"}2.9E-05[a](#tbl12fna){ref-type="table-fn"}0.80.983250.7 × *C*[a](#tbl12fna){ref-type="table-fn"}0.7[a](#tbl12fna){ref-type="table-fn"}1.4E-03[a](#tbl12fna){ref-type="table-fn"}2.2E-05[a](#tbl12fna){ref-type="table-fn"}1.10.9832530.2 × *C*[a](#tbl12fna){ref-type="table-fn"}0.2[a](#tbl12fna){ref-type="table-fn"}4.3E-04[a](#tbl12fna){ref-type="table-fn"}6.6E-06[a](#tbl12fna){ref-type="table-fn"}3.50.981Column 4 (ZVI + BC)111.6 × *C*[a](#tbl12fna){ref-type="table-fn"}1.6[a](#tbl12fna){ref-type="table-fn"}1.4E-03[a](#tbl12fna){ref-type="table-fn"}4.2E-05[a](#tbl12fna){ref-type="table-fn"}0.40.948130.9 × *C*[a](#tbl12fna){ref-type="table-fn"}0.9[a](#tbl12fna){ref-type="table-fn"}8.1E-04[a](#tbl12fna){ref-type="table-fn"}2.4E-05[a](#tbl12fna){ref-type="table-fn"}0.80.961250.7 × *C*[a](#tbl12fna){ref-type="table-fn"}0.7[a](#tbl12fna){ref-type="table-fn"}6.4E-04[a](#tbl12fna){ref-type="table-fn"}1.9E-05[a](#tbl12fna){ref-type="table-fn"}1.00.9422530.2 × *C*[a](#tbl12fna){ref-type="table-fn"}0.2[a](#tbl12fna){ref-type="table-fn"}1.6E-04[a](#tbl12fna){ref-type="table-fn"}4.7E-06[a](#tbl12fna){ref-type="table-fn"}3.90.995[^6][^7]Table 13Zero- or first-order removal constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of **perfluorooctanoic acid (PFOA)***in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. Removal rate constant *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the PFOA concentration. "--" represents no removal of PFOA was observed.Table 13ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^ (μg L^−1^ d^−1^)*k*~*obs*~*k*~*M*~*k*~*SA*~*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)112.2E+01[b](#tbl13fnb){ref-type="table-fn"}2.2E+01[b](#tbl13fnb){ref-type="table-fn"}5.2E-03[b](#tbl13fnb){ref-type="table-fn"}5.5E-04[b](#tbl13fnb){ref-type="table-fn"}1.30.82113------------25------------253------------Column 3 (BC)111.0 × *C*[a](#tbl13fna){ref-type="table-fn"}1.0[a](#tbl13fna){ref-type="table-fn"}2.1E-03[a](#tbl13fna){ref-type="table-fn"}3.3E-05[a](#tbl13fna){ref-type="table-fn"}0.70.980130.5 × *C*[a](#tbl13fna){ref-type="table-fn"}0.5[a](#tbl13fna){ref-type="table-fn"}1.1E-03[a](#tbl13fna){ref-type="table-fn"}1.8E-05[a](#tbl13fna){ref-type="table-fn"}1.30.987251.2E+01[b](#tbl13fnb){ref-type="table-fn"}1.2E+01[b](#tbl13fnb){ref-type="table-fn"}2.5E-02[b](#tbl13fnb){ref-type="table-fn"}3.9E-04[b](#tbl13fnb){ref-type="table-fn"}2.30.9562530.9[b](#tbl13fnb){ref-type="table-fn"}0.9[b](#tbl13fnb){ref-type="table-fn"}1.9E-03[b](#tbl13fnb){ref-type="table-fn"}3.0E-05[b](#tbl13fnb){ref-type="table-fn"}250.780Column 4 (ZVI + BC)112.0E+01[b](#tbl13fnb){ref-type="table-fn"}2.0E+01[b](#tbl13fnb){ref-type="table-fn"}1.8E-02[b](#tbl13fnb){ref-type="table-fn"}5.3E-04[b](#tbl13fnb){ref-type="table-fn"}1.30.935137.7[b](#tbl13fnb){ref-type="table-fn"}7.7[b](#tbl13fnb){ref-type="table-fn"}6.7E-03[b](#tbl13fnb){ref-type="table-fn"}2.0E-04[b](#tbl13fnb){ref-type="table-fn"}3.30.933252.0[b](#tbl13fnb){ref-type="table-fn"}2.0[b](#tbl13fnb){ref-type="table-fn"}1.7E-03[b](#tbl13fnb){ref-type="table-fn"}5.1E-05[b](#tbl13fnb){ref-type="table-fn"}130.725253------------[^8][^9]Table 14Zero- or first-order removal constant (*k*~*obs*~), mass normalized rate constant (*k*~*M*~), surface area normalized rate constant (*k*~*SA*~, specific reaction rate constant), and half-life (*t*~*0.5*~) of **perfluorooctane sulfonic acid (PFOS)***in* Column *ZVI,* Column *BC, and* Column *(ZVI + BC)*. Removal rate constant *k*~*obs*~ is calculated using least-squares regression during two experimental stages. ^ƚ^*C* is the PFOS concentration.Table 14ColumnStagePVRemoval rate^ƚ^,\
μmol L^−1^ d^−1^ (μg L^−1^ d^−1^)*k*~*obs*~*k*~*M*~*k*~*SA*~*t*~*0.5*~,\
d*R*^*2*^Column 2 (ZVI)112.0 × *C*[a](#tbl14fna){ref-type="table-fn"}2.0[a](#tbl14fna){ref-type="table-fn"}4.6E-04[a](#tbl14fna){ref-type="table-fn"}4.9E-05[a](#tbl14fna){ref-type="table-fn"}0.40.911130.9 × *C*[a](#tbl14fna){ref-type="table-fn"}0.9[a](#tbl14fna){ref-type="table-fn"}2.1E-04[a](#tbl14fna){ref-type="table-fn"}2.3E-05[a](#tbl14fna){ref-type="table-fn"}0.80.834252.2E+01[b](#tbl14fnb){ref-type="table-fn"}2.2E+01[b](#tbl14fnb){ref-type="table-fn"}5.1E-03[b](#tbl14fnb){ref-type="table-fn"}5.4E-04[b](#tbl14fnb){ref-type="table-fn"}1.50.9292532.6[b](#tbl14fnb){ref-type="table-fn"}2.6[b](#tbl14fnb){ref-type="table-fn"}6.2E-04[b](#tbl14fnb){ref-type="table-fn"}6.5E-05[b](#tbl14fnb){ref-type="table-fn"}160.734Column 3 (BC)111.8 × *C*[a](#tbl14fna){ref-type="table-fn"}1.8[a](#tbl14fna){ref-type="table-fn"}3.9E-03[a](#tbl14fna){ref-type="table-fn"}6.0E-05[a](#tbl14fna){ref-type="table-fn"}0.40.989130.5 × *C*[a](#tbl14fna){ref-type="table-fn"}0.5[a](#tbl14fna){ref-type="table-fn"}1.2E-03[a](#tbl14fna){ref-type="table-fn"}1.8E-05[a](#tbl14fna){ref-type="table-fn"}1.30.511250.9 × *C*[a](#tbl14fna){ref-type="table-fn"}0.9[a](#tbl14fna){ref-type="table-fn"}1.8E-03[a](#tbl14fna){ref-type="table-fn"}2.8E-05[a](#tbl14fna){ref-type="table-fn"}0.80.9612530.2 × *C*[a](#tbl14fna){ref-type="table-fn"}0.2[a](#tbl14fna){ref-type="table-fn"}4.6E-04[a](#tbl14fna){ref-type="table-fn"}7.2E-06[a](#tbl14fna){ref-type="table-fn"}3.20.967Column 4 (ZVI + BC)112.2 × *C*[a](#tbl14fna){ref-type="table-fn"}2.2[a](#tbl14fna){ref-type="table-fn"}1.9E-03[a](#tbl14fna){ref-type="table-fn"}5.7E-05[a](#tbl14fna){ref-type="table-fn"}0.30.974130.7 × *C*[a](#tbl14fna){ref-type="table-fn"}0.7[a](#tbl14fna){ref-type="table-fn"}5.8E-04[a](#tbl14fna){ref-type="table-fn"}1.7E-05[a](#tbl14fna){ref-type="table-fn"}1.10.881251.1 × *C*[a](#tbl14fna){ref-type="table-fn"}1.1[a](#tbl14fna){ref-type="table-fn"}9.6E-04[a](#tbl14fna){ref-type="table-fn"}2.9E-05[a](#tbl14fna){ref-type="table-fn"}0.60.9622537.0[b](#tbl14fnb){ref-type="table-fn"}7.0E+01[b](#tbl14fnb){ref-type="table-fn"}6.1E-03[b](#tbl14fnb){ref-type="table-fn"}1.8E-04[b](#tbl14fnb){ref-type="table-fn"}5.90.966[^10][^11]

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Materials {#sec2.1}
--------------

The native analyte compounds carbamazepine (CBZ), caffeine (CAF), sulfamethoxazole (SMX), ibuprofen (IBU), gemfibrozil (GEM), naproxen (NAP), cyclamate (CYC), and saccharin (SAC) for calibration standards and input stock solution were obtained from Sigma-Aldrich (Oakville, ON, Canada). The isotope-labeled standards CBZ-d10, CAF-d3, IBU-d3, GEM-d6, and \[^13^C\]-NAP were obtained from Cambridge Isotope Laboratory Inc. (Tewksbury, MA, USA). The native analytes acesulfame-K (ACE-K), sucralose (SCL), and the isotope-labeled standards SMX-d4, CYC-d11, SAC-^13^C6, ACE-K-d4, and SCL-d6 were obtained from Toronto Research Chemicals Inc. (Toronto, ON, Canada). The native analytes 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), and isotope-labeled MDA-d5 and MDMA-d5 were obtained from Cerilliant Corporation (Round Rock, TX, USA). The native analytes perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and their isotope-labeled standards \[^13^C\]-PFOA and \[^13^C\]-PFOS were obtained from Wellington Laboratories Inc. (Guelph, ON, Canada). The analytes PFOA and PFOS as dry powder for preparation of the input stock solution were obtained from Sigma-Aldrich, Canada. The silica sand (SS; 0.6--0.8 mm) was obtained from US Silica Company Inc. (Ottawa, IL, USA). The granular zero-valent iron (ZVI; 0.25--1.19 mm) was obtained from Connelly-GPM Inc. (Chicago, IL, USA). The biochar (BC; oak hard wood; 0.50--2.36 mm) was obtained from Cowboy Charcoal Co. (Brentwood, TN, USA).

2.2. Column experimental design {#sec2.2}
-------------------------------

Four acrylic columns were used, each column was 30 cm in length and 5 cm inner diameter. Influent and effluent ports were installed on the bottom and top of each column, respectively, for introducing input solution and discharging effluent. Seven sampling ports were installed along the length of each column at 3.75-cm intervals for profile sampling. Column *Control* was packed with 100% SS. Column *ZVI* and Column *BC* were packed with 50% (vol%) of ZVI and BC, respectively, and balanced with SS. Column *(ZVI + BC)* was packed with 10% (vol%) of ZVI, 40% (vol%) of BC, and balanced with SS.

Input solution contained 10 μg L^−1^ of pharmaceuticals CBZ, CAF, SMX, MDA, MDMA, IBU, GEM, and NAP; 100 μg L^−1^ of artificial sweeteners ACE-K, CYC, SAC, and SCL; and 50 μg L^−1^ of PFOA and 20--100 μg L^−1^ of PFOS. The input solution was pumped through four columns from bottom to top at a flow rate of 0.3 pore volume (PV) d^−1^ before 50 PV during the first stage of the experiment; the flow rate was decreased to 0.1 PV d^−1^ after 50 PV during the second stage of the experiment. Three profile samplings (along the length of the columns) were performed during the first stage of the experiment after 1, 13, and 25 PV of flow through the columns; one profile sampling was conducted during the second stage of the experiment after 53 PV of flow.

All the emerging contaminant samples were spiked with isotopically-labeled internal standards before analysis. The pharmaceutical, PFOA, and PFOS samples were then concentrated through a solid phase extraction (SPE) process; their concentrations were determined using liquid chromatography (LC) followed by tandem mass spectrometry (MS). The concentrations of artificial sweeteners were directly analyzed by ion chromatography (IC) followed by MS without SPE. Detailed information on column experimental setup and analytical procedures for target emerging contaminants are summarized by Liu et al. \[[@bib1]\].

2.3. Removal kinetics of target emerging contaminants by ZVI, BC, and (*ZVI + BC*) {#sec2.3}
----------------------------------------------------------------------------------

The removal rates (*k*~*obs*~) for target emerging contaminants during two experimental stages were calculated using least-squares regression in SigmaPlot. The removal of target pharmaceuticals within Columns *ZVI*, *BC*, and *(ZVI+BC)* followed a first-order rate model reported by Liu et al. \[[@bib1]\] that can be described by equation [(1)](#fd1){ref-type="disp-formula"}. *k*~*M*~ and *k*~*SA*~ were calculated according to equations [(2)](#fd2){ref-type="disp-formula"}, [(3)](#fd3){ref-type="disp-formula"} which are defined by Johnson et al. \[[@bib2]\]. The half-life (t~0.5~) of the first-order rate for target pharmaceuticals was calculated following equation [(4)](#fd4){ref-type="disp-formula"}.$$\  - \frac{dC}{dt} = k_{obs}\ C$$$$k_{M} = \frac{k_{obs}}{\rho_{m}}$$$$k_{SA} = \frac{k_{obs}}{\rho_{a}} = \frac{k_{M}}{a_{s}}$$$$t_{0.5} = \frac{0.693}{k_{obs}}$$where *C* is the contaminant concentration (μmol L^−1^ or μg L^−1^), *k*~*obs*~ is the first-order removal rate constant (d^−1^), *k*~*M*~ is the mass normalized first-order rate constant (L g^−1^ d^−1^), *k*~*SA*~ is the specific first-order reaction rate constant or surface area normalized first-order rate constant (L m^−2^ d^−1^), *ρ*~*m*~ is the mass concentration of reactive media (g L^−1^ of solution), *ρ*~*a*~ is the surface area concentration of reactive media (m^2^ L^−1^ of solution), *a*~*s*~ is the specific surface area of reactive media (m^2^ g^−1^), and t~0.5~ is the half-life of contaminant (d). The specific surface areas of the reactive media ZVI, BC, and (ZVI + BC) used are 9.5, 64.5, and 33.6 m^2^ g^−1^ which are reported previously \[[@bib3],[@bib4]\].

The removal of artificial sweeteners, PFOA, and PFOS within three treatment columns followed a first- or zero-order rate model or followed a first-order rate in the early stage of the experiment followed by a zero-order rate in the late stage of the experiment \[[@bib1]\]. The *k*~*obs*~, *k*~*M*~, *k*~*SA*~, and t~0.5~ for the first-order rate of artificial sweeteners, PFOA, and PFOS were calculated following the equations [(1)--(4)](#fd1){ref-type="disp-formula"}. The zero-order rate model can be described by equation [(5)](#fd5){ref-type="disp-formula"}. *k*~*M*~ and *k*~*SA*~ for the zero-order reaction can also be calculated according to equations [(2)](#fd2){ref-type="disp-formula"}, [(3)](#fd3){ref-type="disp-formula"}. However, the half-life (t~0.5~) of the zero-order reaction for target artificial sweeteners, PFOA, and PFOS was calculated following equation [(6)](#fd6){ref-type="disp-formula"}.$$- \frac{dC}{dt} = k_{obs}\ $$$$t_{0.5} = \frac{C_{0}}{2\ k_{obs}}$$where *C*~*0*~ is the initial contaminant concentration (μmol L^−1^ or μg L^−1^). The units of *k*~*obs*~, *k*~*M*~, and *k*~*SA*~ for the zero-order rate were different from that for the first order rate. For the zero-order rate, the unit of *k*~*obs*~ is μmol contaminant L^−1^ d^−1^ (μg contaminant L^−1^ d^−1^), the unit of *k*~*M*~ is μmol contaminant d^−1^ g ^−1^ (μg contaminant d^−1^ g ^−1^), and the unit of *k*~*SA*~ is μmol contaminant d^−1^ m^−2^ (μg contaminant d^−1^ m^−2^).
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[^1]: Removal of acesulfame-K followed a first-order reaction rate, unit of *k*~*obs*~ is d^−1^, unit of *k*~*M*~ is L g^−1^ d^−1^, unit of *k*~*SA*~ is L m^−2^ d^−1^.

[^2]: Removal of acesulfame-K followed a zero-order reaction rate, unit of *k*~*obs*~ is μmol acesulfame-K L^−1^ d^−1^ (μg acesulfame-K L^−1^ d^−1^), unit of *k*~*M*~ is μmol acesulfame-K d^−1^ g ^−1^ (μg acesulfame-K d^−1^ g ^−1^), unit of *k*~*SA*~ is μmol acesulfame-K d^−1^ m^−2^ (μg acesulfame-K d^−1^ m^−2^).

[^3]: Note: The poor *R*^*2*^ values at 1 PV in this table are likely due to little removal of cyclamate in the three treatment columns.

[^4]: Removal of saccharin followed a first-order reaction rate, unit of *k*~*obs*~ is d^−1^, unit of *k*~*M*~ is L g^−1^ d^−1^, unit of *k*~*SA*~ is L m^−2^ d^−1^.

[^5]: Removal of saccharin followed a zero-order reaction rate, unit of *k*~*obs*~ is μmol saccharin L^−1^ d^−1^ (μg saccharin L^−1^ d^−1^), unit of *k*~*M*~ is μmol saccharin d^−1^ g ^−1^ (μg saccharin d^−1^ g ^−1^), unit of *k*~*SA*~ is μmol saccharin d^−1^ m^−2^ (μg saccharin d^−1^ m^−2^).

[^6]: Removal of sucralose followed a first-order reaction rate, unit of *k*~*obs*~ is d^−1^, unit of *k*~*M*~ is L g^−1^ d^−1^, unit of *k*~*SA*~ is L m^−2^ d^−1^.

[^7]: Removal of sucralose followed a zero-order reaction rate, unit of *k*~*obs*~ is μmol sucralose L^−1^ d^−1^ (μg sucralose L^−1^ d^−1^), unit of *k*~*M*~ is μmol sucralose d^−1^ g ^−1^ (μg sucralose d^−1^ g ^−1^), unit of *k*~*SA*~ is μmol sucralose d^−1^ m^−2^ (μg sucralose d^−1^ m^−2^).

[^8]: Removal of PFOA followed a first-order reaction rate, unit of *k*~*obs*~ is d^−1^, unit of *k*~*M*~ is L g^−1^ d^−1^, unit of *k*~*SA*~ is L m^−2^ d^−1^.

[^9]: Removal of PFOA followed a zero-order reaction rate, unit of *k*~*obs*~ is μmol PFOA L^−1^ d^−1^ (μg PFOA L^−1^ d^−1^), unit of *k*~*M*~ is μmol PFOA d^−1^ g ^−1^ (μg PFOA d^−1^ g ^−1^), unit of *k*~*SA*~ is μmol PFOA d^−1^ m^−2^ (μg PFOA d^−1^ m^−2^).

[^10]: Removal of PFOS followed a first-order reaction rate, unit of *k*~*obs*~ is d^−1^, unit of *k*~*M*~ is L g^−1^ d^−1^, unit of *k*~*SA*~ is L m^−2^ d^−1^.

[^11]: Removal of PFOS followed a zero-order reaction rate, unit of *k*~*obs*~ is μmol PFOS L^−1^ d^−1^ (μg PFOS L^−1^ d^−1^), unit of *k*~*M*~ is μmol PFOS d^−1^ g ^−1^ (μg PFOS d^−1^ g ^−1^), unit of *k*~*SA*~ is μmol PFOS d^−1^ m^−2^ (μg PFOS d^−1^ m^−2^).
